2011
,
Inhibition of fatty acid synthase suppresses topoisomerase 1 activity by up-regulating intracellular polyunsaturated fatty acid and synergistically enhances SN-38, an active metabolite of the topoisomerase 1 inhibitor irinotecan-induced cytotoxicity